BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32976832)

  • 1. LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance.
    Zhou Y; Sun W; Qin Z; Guo S; Kang Y; Zeng S; Yu L
    Biochem Pharmacol; 2021 Jul; 189():114228. PubMed ID: 32976832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to platinum-based cancer drugs: a special focus on epigenetic mechanisms.
    Mora Y; Reyes ME; Zanella L; Mora B; Buchegger K; Ili C; Brebi P
    Pharmacogenomics; 2021 Aug; 22(12):777-790. PubMed ID: 34281355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNAs in cancer drug resistance development.
    Majidinia M; Yousefi B
    DNA Repair (Amst); 2016 Sep; 45():25-33. PubMed ID: 27427176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK.
    Si X; Zang R; Zhang E; Liu Y; Shi X; Zhang E; Shao L; Li A; Yang N; Han X; Pan B; Zhang Z; Sun L; Sun Y
    Oncotarget; 2016 Dec; 7(49):81452-81462. PubMed ID: 27845892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNAs as biotargets in cisplatin-based drug resistance.
    Abu N; Hon KW; Jeyaraman S; Jamal R
    Future Oncol; 2018 Dec; 14(29):3085-3095. PubMed ID: 30468082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review: Regulation of the cancer epigenome by long non-coding RNAs.
    Forrest ME; Khalil AM
    Cancer Lett; 2017 Oct; 407():106-112. PubMed ID: 28400335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced modifications and modulations of microRNAs and long non-coding RNAs for future therapy against Glioblastoma Multiforme.
    Janaki Ramaiah M; Divyapriya K; Kartik Kumar S; Rajesh YBRD
    Gene; 2020 Jan; 723():144126. PubMed ID: 31589963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Epigenetic Therapy to Overcome Chemotherapy Resistance.
    Strauss J; Figg WD
    Anticancer Res; 2016 Jan; 36(1):1-4. PubMed ID: 26722021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs.
    Jiang W; Xia J; Xie S; Zou R; Pan S; Wang ZW; Assaraf YG; Zhu X
    Drug Resist Updat; 2020 May; 50():100683. PubMed ID: 32146422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNAs and their implications in cancer epigenetics.
    Beckedorff FC; Amaral MS; Deocesano-Pereira C; Verjovski-Almeida S
    Biosci Rep; 2013 Aug; 33(4):. PubMed ID: 23875687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
    Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
    Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between long non-coding RNAs and epigenetic machinery: emerging targets in cancer?
    Hanly DJ; Esteller M; Berdasco M
    Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics.
    Li Y; Li Z; Zhu WG
    Curr Med Chem; 2019; 26(8):1328-1350. PubMed ID: 28933282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer's epigenetic drugs: where are they in the cancer medicines?
    Ghasemi S
    Pharmacogenomics J; 2020 Jun; 20(3):367-379. PubMed ID: 31819161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
    Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
    Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome‑wide DNA methylation regulation analysis of long non‑coding RNAs in glioblastoma.
    Ji J; Zhao L; Zhao X; Li Q; An Y; Li L; Li D
    Int J Mol Med; 2020 Jul; 46(1):224-238. PubMed ID: 32319552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic gene regulation in cancer.
    Ballestar E; Esteller M
    Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA epigenetics in pulmonary diseases: Insights into methylation modification of lncRNAs in lung cancer.
    Jiang J; Duan M; Wang Z; Lai Y; Zhang C; Duan C
    Biomed Pharmacother; 2024 Jun; 175():116704. PubMed ID: 38749181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation and gene expression profiles characterize epigenetic regulation of lncRNAs in colon adenocarcinoma.
    Li Z; Tan H; Yu H; Deng Z; Zhou X; Wang M
    J Cell Biochem; 2020 Mar; 121(3):2406-2415. PubMed ID: 31692079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of Epigenetic Regulation by Long Noncoding RNAs in Cancer.
    Morlando M; Fatica A
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29443889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.